Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q3 2022 · 10-Q
Revenue—
Net Income-$3.10M-$3.10MN/M vs Q3 2021 EPS Diluted-$0.04-$0.04N/M vs Q3 2021 Operating Income-$2,866,536N/M Operating Cash Flowderived-$970,018N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Apr 30, 2022 · filed Jun 14, 2022 · 45 d after period end